testwell OÜ

In liquidation Registry code 17074347 OÜ Tallinn Registered 20 Sep 2024
Compare

testwell OÜ is a OÜ based in Tallinn, registry code 17074347, status: in liquidation. Main activity: Manufacture of basic pharmaceutical products. Its annual report for 2025 shows revenue of €0 and 0 employees.

Revenue
0 €
↓ 100.0% vs 2024
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Manufacture of basic pharmaceutical products and pharmaceutical preparations · EMTAK 21

  • Revenue · 2025 0 €
    industry median 48 003 € · companies in the industry: 19

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2024 – 2026
Revenue, € 2025: 0 € · −100.0% vs 2024 · industry median 48 003 € · above 5% of the industry
010 00020 00030 00040 00050 0002024 Company: 598 € Industry median: 25 284 €20242025 Company: 0 € Industry median: 48 003 €20252026 Company: — Industry median: —2026010 00020 00030 00040 00050 0002024 Company: 598 € Industry median: 25 284 €20242025 Company: 0 € Industry median: 48 003 €2026 Company: — Industry median: —2026
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -97 € · −145.5% vs 2024 · industry median 676 € · above 30% of the industry
-20002004006008002024 Company: 213 € Industry median: 0 €20242025 Company: -97 € Industry median: 676 €20252026 Company: — Industry median: —2026-20002004006008002024 Company: 213 € Industry median: 0 €20242025 Company: -97 € Industry median: 676 €2026 Company: — Industry median: —2026
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 216 € · −31.0% vs 2024
01002003004002024 Company: 313 €20242025 Company: 216 €20252026 Company: —202601002003004002024 Company: 313 €20242025 Company: 216 €2026 Company: —2026
Equity, € 2025: 216 € · −31.0% vs 2024
01002003004002024 Company: 313 €20242025 Company: 216 €20252026 Company: —202601002003004002024 Company: 313 €20242025 Company: 216 €2026 Company: —2026
Employees 2026: 0
0102030402024 Company: 0 Industry median: 3220242025 Company: 0 Industry median: 2820252026 Company: 0 Industry median: —20260102030402024 Company: 0 Industry median: 3220242025 Company: 0 Industry median: 282026 Company: 0 Industry median: —2026
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2026 — — — — — 0
2025 0 -97 0 216 216 0
2024 598 213 0 313 313 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-44.9 %
Net profit / equity
Return on assets (ROA)
-44.9 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 29 Jun 2026 Company’s own e-Äriregister
2024 20 Sep 2024 – 31 Dec 2024 1 Jul 2025 Company’s own e-Äriregister

Board

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 21101Manufacture of basic pharmaceutical products Main

History of changes

What Value Period
Status In liquidation 9 Sep 2026 – now
Status Active 20 Sep 2024 – now
Rulings
Number, date Title Deadline State Document
Ä 50264650 / 5
9 Sep 2026
Termination entry In force
9 Sep 2026
PDF
Ä 50264650 / 4
30 May 2025
Amendment under Code of Civil Procedure § 595¹ (1) In force
30 May 2025
PDF
Ä 50264650 / 3
1 Nov 2024
Amendment entry In force
1 Nov 2024
PDF
Ä 50264650 / M1
28 Oct 2024
Ruling to eliminate deficiencies 12 Nov 2024 In force
13 Nov 2024
PDF
Ä 50264650 / 2
15 Oct 2024
Amendment entry In force
15 Oct 2024
PDF
Ä 50264650
20 Sep 2024
First entry In force
20 Sep 2024
PDF

Sources: e-Äriregister and EMTA. Data updated 30 Oct 2026. Open at the source ↗ · Report an error in the data